When GLP-1s Stop Working: Understanding Plateaus and What to Do Next

You started strong. The weight was coming off, your energy was up, and you felt like you’d finally found something that worked. Then, somewhere around month four or six, things slowed down. The scale stopped moving. You’ve hit a plateau. Is the medication failing you, or is something else going on?

First, Plateaus Are Normal

Weight loss plateaus happen on GLP-1 medications, just as they do with any approach to weight management. Your body is remarkably good at adapting. As you lose weight, your metabolism adjusts. You burn fewer calories at a lower body weight, and your body may fight harder to hold onto what it has.

This doesn’t mean the medication isn’t working. In fact, a plateau while on a GLP-1 medication may mean the drug is still actively preventing regain and doing important metabolic work, even if the scale isn’t moving.

How Long Is Too Long?

A few weeks of slowed progress is very common and usually resolves on its own. But if the scale hasn’t budged in three months or more, it may be worth a closer look at what’s happening.

Check the Basics First

Before assuming the medication is no longer working, honestly assess the following:

• Has your eating crept back up? The appetite suppression from GLP-1 medications can lessen over time for some people, allowing old habits to slowly return.

• Are you tracking your protein intake? Inadequate protein can lead to muscle loss, which lowers your metabolic rate.

• Has your activity level changed? Exercise, especially strength training, becomes increasingly important as weight loss continues.

• Are you sleeping enough? Poor sleep disrupts hunger hormones and can stall progress.

• Are you under significant stress? Cortisol elevates blood sugar and can interfere with weight loss.

Consider Adding Strength Training

This is often the missing piece for people on a plateau. As you lose weight on GLP-1 medications, you’re at risk of losing muscle mass along with fat, especially if you’re eating significantly less and not resistance training. Muscle is metabolically active. Losing it makes future weight loss harder. Adding two to three sessions of strength training per week and ensuring adequate protein intake can help break a plateau and protect your metabolism.

Talk to Your Doctor About Dosing

If you’re not at your maximum tolerated dose, a conversation about increasing may be appropriate. Many people see renewed progress after a dose increase. Dose increases can sometimes bring a return of side effects like nausea, vomiting, or constipation, so it is important to work closely with your provider to find the right balance.

When To Consider Switching Medications

If you’ve been on semaglutide for an extended period with limited results, your doctor may discuss switching to tirzepatide, which targets both GLP-1 and an additional hormone receptor (GIP) and tends to produce greater weight loss on average.

The Psychological Side of Plateaus

Plateaus can be deeply discouraging, especially after seeing significant early progress. It’s important not to let frustration lead you to abandon a medication that is still providing real metabolic benefits, even if weight loss has temporarily stalled. Discuss how you’re feeling with your doctor and consider working with a therapist or health coach if the emotional weight of the plateau is significant.

What a Plateau Actually Means

Plateaus are a normal part of the weight loss journey, even on medications like GLP-1 agonists. They’re usually not a sign of failure. They’re a signal to evaluate, adjust, and keep going. Stay in close contact with your healthcare team, revisit your habits, and remember that your progress isn’t defined entirely by the number on the scale.

The FDA-approved GLP-1 receptor agonist medications discussed in this article are prescription medications for specific indications: semaglutide (Ozempic®) for type 2 diabetes and to reduce cardiovascular risk in adults with type 2 diabetes and cardiovascular disease; semaglutide (Wegovy®) for chronic weight management; tirzepatide (Mounjaro®) for type 2 diabetes; and tirzepatide (Zepbound®) for chronic weight management. This article is for educational and informational purposes only and does not constitute medical advice. Individual results may vary. Consult your healthcare provider to determine if GLP-1 therapy is appropriate for your individual health situation and to discuss potential risks, side effects, and contraindications.

Writing Staff